scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1875-5364(11)60010-1 |
P50 | author | Thomas Efferth | Q53683811 |
P2093 | author name string | Thomas EFFERTH | |
P2860 | cites work | Next-generation model-based drug discovery and development: quantitative and systems pharmacology | Q37763515 |
Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy | Q37782112 | ||
Medicinal plant biotechnology | Q37782959 | ||
Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine. | Q37801337 | ||
A unique issue in the standardization of Chinese materia medica: processing | Q37807005 | ||
Perspective of Chemical Fingerprinting of Chinese Herbs | Q37808393 | ||
GAP Production of TCM Herbs in China | Q37809496 | ||
Probing the Biology of Natural Products: Molecular Editing by Diverted Total Synthesis | Q37809500 | ||
Agricultural production of artemisinin--a review | Q40684304 | ||
A database of 389 medicinal plants for diabetes | Q42747270 | ||
Venezuelan project establishes indigenous plant database | Q42778963 | ||
A database on endemic plants at Tirumala hills in India | Q43063760 | ||
Carbon nanotube reinforced hollow fiber solid/liquid phase microextraction: a novel extraction technique for the measurement of caffeic acid in Echinacea purpurea herbal extracts combined with high-performance liquid chromatography | Q43130545 | ||
Chromatographic fingerprint investigation for quality evaluation and control of Shengui hair-growth tincture | Q43275991 | ||
Development of a DNA microarray for authentication of ginseng drugs based on 18S rRNA gene sequence | Q45871707 | ||
Rapid authentication of Bupleurum species using an array of immobilized sequence-specific oligonucleotide probes | Q46592294 | ||
Evidence-based Chinese medicine for cancer therapy. | Q46775915 | ||
Taxonomy. Wanted: a barcode for plants | Q48077076 | ||
Authentication is fundamental for standardization of Chinese medicines | Q48700015 | ||
[Does the utilization of traditional Chinese herbs threaten the biodiversity?] | Q80613201 | ||
Total synthesis of qinghaosu | Q22061918 | ||
Use of ITS2 Region as the Universal DNA Barcode for Plants and Animals | Q27318707 | ||
Molecular Target-Guided Tumor Therapy with Natural Products Derived from Traditional Chinese Medicine | Q29031416 | ||
Preserving the evolutionary potential of floras in biodiversity hotspots | Q33273864 | ||
Development of liquid chromatography/mass spectrometry methods for the quantitative analysis of herbal medicine in biological fluids: a review | Q33489728 | ||
Metabolomics of medicinal plants: the importance of multivariate analysis of analytical chemistry data | Q33605254 | ||
An integrated web medicinal materials DNA database: MMDBD (Medicinal Materials DNA Barcode Database) | Q33615224 | ||
Successful isolation and PCR amplification of DNA from National Institute of Standards and Technology herbal dietary supplement standard reference material powders and extracts | Q34156230 | ||
The genetics of artemisinin content in Artemisia annua L. and the breeding of high yielding cultivars | Q34482089 | ||
Microbial contamination of medicinal plants--a review | Q34528302 | ||
Antibody-based therapeutics to watch in 2011 | Q34570079 | ||
Bioprocessing of plant cell cultures for mass production of targeted compounds. | Q34984372 | ||
Integration of herbal medicine into modern medical practices: issues and prospects | Q35604677 | ||
Chinese medicinal materials and their interface with Western medical concepts | Q35978665 | ||
Approach to communicating with patients about the use of nutritional supplements in cancer care | Q36090420 | ||
Medical provision in Africa - Past and present | Q36326823 | ||
Combinatorial biosynthesis of medicinal plant secondary metabolites | Q36627678 | ||
Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside | Q36758444 | ||
Hairy root culture for mass-production of high-value secondary metabolites | Q36761508 | ||
Production of artemisinin by genetically-modified microbes | Q37002883 | ||
Growth of hairy-root cultures in various bioreactors for the production of secondary metabolites | Q37034403 | ||
Metabolomics for phytomedicine research and drug development | Q37079380 | ||
Pharmaceutically active natural product synthesis and supply via plant cell culture technology | Q37130422 | ||
The use of genomics in clinical trial design | Q37284262 | ||
Metabolomics for functional genomics, systems biology, and biotechnology | Q37371858 | ||
Application of plant tissue cultures in phytoremediation research: incentives and limitations | Q37421893 | ||
New perspectives for synergy research with the "omic"-technologies | Q37475879 | ||
Paving roads for new drugs in oncology | Q37516202 | ||
Perspectives and limits of engineering the isoprenoid metabolism in heterologous hosts. | Q37577695 | ||
An introduction to liquid chromatography-mass spectrometry instrumentation applied in plant metabolomic analyses | Q37635785 | ||
Economic opportunities and challenges for pharmacogenomics | Q37670231 | ||
P433 | issue | 1 | |
P304 | page(s) | 1-6 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Chinese Journal of Natural Medicines | Q15817382 |
P1476 | title | Perspectives for Globalized Natural Medicines | |
P478 | volume | 9 |
Q37571806 | Simultaneous Determination of Bergapten, Imperatorin, Notopterol, and Isoimperatorin in Rat Plasma by High Performance Liquid Chromatography with Fluorescence Detection and Its Application to Pharmacokinetic and Excretion Study after Oral Administra | cites work | P2860 |
Search more.